Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;101(3):705-713.
doi: 10.3233/JAD-240334.

Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease

Tracy Butler  1 , Sin-Ruow Tey  2 , James E Galvin  3 , George Perry  4 , Richard L Bowen  5 , Craig S Atwood  6   7
Affiliations
Review

Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease

Tracy Butler et al. J Alzheimers Dis. 2024.

Abstract

The increase in the incidence of dementia over the last century correlates strongly with the increases in post-reproductive lifespan during this time. As post-reproductive lifespan continues to increase it is likely that the incidence of dementia will also increase unless therapies are developed to prevent, slow or cure dementia. A growing body of evidence implicates age-related endocrine dyscrasia and the length of time that the brain is subjected to this endocrine dyscrasia, as a key causal event leading to the cognitive decline associated with aging and Alzheimer's disease (AD), the major form of dementia in our society. In particular, the elevations in circulating gonadotropins, resulting from the loss of gonadal sex hormone production with menopause and andropause, appear central to the development of AD neuropathology and cognitive decline. This is supported by numerous cell biology, preclinical animal, and epidemiological studies, as well as human clinical studies where suppression of circulating luteinizing hormone and/or follicle-stimulating hormone with either gonadotropin-releasing hormone analogues, or via physiological hormone replacement therapy, has been demonstrated to halt or significantly slow cognitive decline in those with AD. This review provides an overview of past and present studies demonstrating the importance of hypothalamic-pituitary-gonadal hormone balance for normal cognitive functioning, and how targeting age-related endocrine dyscrasia with hormone rebalancing strategies provides an alternative treatment route for those with AD.

Keywords: 17β-estradiol; Alzheimer’s disease; GnRH analogues; amyloid-β; andropause; cell cycle; cognition; endocrine dyscrasia; gonadotropins; hypothalamic-pituitary-gonadal axis; menopause; neurodegeneration; neuropathology; progesterone; tau.

PubMed Disclaimer

Similar articles

See all similar articles

LinkOut - more resources